Safgren SL - Search Results

1

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921).

Mossé YP, Fox E, Teachey DT, Reid JM, Safgren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall D, Barkauskas DA, Krailo M, Voss SD, Berg SL, Blaney SM, Weigel BJ. Mossé YP, et al. Among authors: safgren sl. Clin Cancer Res. 2019 Jun 1;25(11):3229-3238. doi: 10.1158/1078-0432.CCR-18-2675. Epub 2019 Feb 18. Clin Cancer Res. 2019. PMID: 30777875 Free PMC article. Clinical Trial.

2

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.

Rajkumar SV, Reid JM, Novotny PJ, Safgren SL, Scheithauer BW, Johnson PS, Nair S, Morton RF, Hatfield AK, Krook JE, Ames MM, Buckner JC; North Central Cancer Treatment Group. Rajkumar SV, et al. Among authors: safgren sl. J Neurooncol. 2000 Sep;49(3):255-61. doi: 10.1023/a:1006454427026. J Neurooncol. 2000. PMID: 11212905 Clinical Trial.

3

Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide.

Safgren SL, Reid JM, Rios R, Ames MM. Safgren SL, et al. J Chromatogr B Biomed Sci Appl. 2001 Apr 15;754(1):91-6. doi: 10.1016/s0378-4347(00)00586-7. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11318431

4

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).

Galanis E, Goldberg R, Reid J, Atherton P, Sloan J, Pitot H, Rubin J, Adjei AA, Burch P, Safgren SL, Witzig TE, Ames MM, Erlichman C. Galanis E, et al. Among authors: safgren sl. Ann Oncol. 2001 May;12(5):701-7. doi: 10.1023/a:1011182123545. Ann Oncol. 2001. PMID: 11432631 Free article. Clinical Trial.

5

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.

Steinherz PG, Seibel NL, Ames MM, Avramis VI, Krailo MD, Liu-Mares W, Reid JM, Safgren SL, Reaman GH. Steinherz PG, et al. Among authors: safgren sl. Leuk Lymphoma. 2002 Oct;43(10):1945-50. doi: 10.1080/1042819021000015880. Leuk Lymphoma. 2002. PMID: 12481889 Clinical Trial.

6

Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.

Reid JM, Qu W, Safgren SL, Ames MM, Krailo MD, Seibel NL, Kuttesch J, Holcenberg J. Reid JM, et al. Among authors: safgren sl. J Clin Oncol. 2004 Jun 15;22(12):2445-51. doi: 10.1200/JCO.2004.10.142. J Clin Oncol. 2004. PMID: 15197207 Clinical Trial.

7

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S, Adjei AA, Sloan J, Atherton P, Vasile V, Salazaar S, Adjei A, Croghan G, Erlichman C. Goetz MP, et al. J Clin Oncol. 2005 Feb 20;23(6):1078-87. doi: 10.1200/JCO.2005.09.119. J Clin Oncol. 2005. PMID: 15718306 Clinical Trial.

8

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.

Molina JR, Reid JM, Erlichman C, Sloan JA, Furth A, Safgren SL, Lathia CD, Alberts SR. Molina JR, et al. Among authors: safgren sl. Anticancer Drugs. 2005 Oct;16(9):997-1002. doi: 10.1097/01.cad.0000176504.86551.5c. Anticancer Drugs. 2005. PMID: 16162976 Clinical Trial.

9

Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.

Kaufmann SH, Karp JE, Letendre L, Kottke TJ, Safgren S, Greer J, Gojo I, Atherton P, Svingen PA, Loegering DA, Litzow MR, Sloan JA, Reid JM, Ames MM, Adjei AA, Erlichman C. Kaufmann SH, et al. Clin Cancer Res. 2005 Sep 15;11(18):6641-9. doi: 10.1158/1078-0432.CCR-05-0817. Clin Cancer Res. 2005. PMID: 16166443 Clinical Trial.

10

A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer.

Nowakowski GS, McCollum AK, Ames MM, Mandrekar SJ, Reid JM, Adjei AA, Toft DO, Safgren SL, Erlichman C. Nowakowski GS, et al. Among authors: safgren sl. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6087-93. doi: 10.1158/1078-0432.CCR-06-1015. Clin Cancer Res. 2006. PMID: 17062684 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page